# FDA Inspection 1264953 - CCRM New York - March 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/ccrm-new-york/a9e7eb4f-95c8-435b-a72d-3e4192899f62
Source feed: FDA_Inspections

> FDA Inspection 1264953 for CCRM New York on March 21, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264953
- Company Name: CCRM New York
- Inspection Date: 2025-03-21
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1264953 - 2025-03-21](https://www.keypedia.com/records/fda_inspections/ccrm-new-york/b3642e98-b44c-4e08-a33e-4e3a3b1c24e5)
- [FDA Inspection 1187297 - 2022-10-25](https://www.keypedia.com/records/fda_inspections/ccrm-new-york/43f3073f-5dae-4f4f-a1a2-05623027afd7)
- [FDA Inspection 1187297 - 2022-10-25](https://www.keypedia.com/records/fda_inspections/ccrm-new-york/196a759e-dd13-4ab3-a43c-54b2ad538658)
- [FDA Inspection 1187297 - 2022-10-25](https://www.keypedia.com/records/fda_inspections/ccrm-new-york/e97313ed-b557-467e-b930-c0b26bbe7ef8)
- [FDA Inspection 1100091 - 2019-08-21](https://www.keypedia.com/records/fda_inspections/ccrm-new-york/92fd799a-c447-4d4b-bdea-1923d680a3aa)

Company: https://www.keypedia.com/companies/ccrm-new-york/00ede195-0d06-4623-b641-66973735195a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d